HAMP and type 2 diabetes mellitus: The alterations in AMP abundance were investigated by other groups; the main finding of El-Mowafy’s group was the significant elevation of the α-defensin [39], while Vela et al.’s study showed a decrease in hepcidin levels in the sera of T2D patients compared with controls [40].